People: Ironwood Pharmaceuticals Inc (IRWD.O)
14 Jun 2019
Dr. Mark G. Currie, Ph.D. is Senior Vice President, Chief Scientific Officer, President - Research and Development, Director of the Company. He directed cardiovascular and central nervous system disease research as vice president of discovery research at Sepracor Inc. Previously, Dr. Currie initiated, built and led discovery pharmacology and also served as director of arthritis and inflammation at Monsanto Company. Dr. Currie earned a B.S. in biology from the University of South Alabama and holds a Ph.D. in cell biology from the Bowman-Gray School of Medicine of Wake Forest University.
|Total Annual Compensation, USD||680,000|
|Restricted Stock Awards, USD||--|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||1,944,690|
|Fiscal Year Total, USD||2,624,690|